Levi & Korsinsky notifies investors that it has commenced an investigation into The Cigna Group (NYSE: CI) concerning potential violations of the federal securities laws.
On October 30, 2025, before the market opened, CI published third quarter 2025 earnings results highlighting the company’s performance expectations for the coming years. CI disclosed its Healthcare MCR was 84.8% for third quarter 2025 compared to 82.8% for third quarter 2024, reducing the Company’s future profitability. Management attributed it to the Company’s Individual and Family Plans business and higher stop loss medical costs relative to the prior year. In direct response to this news, CI’s stock price fell by $52.02 (17%) per share to close at $247.10 per share on October 30, 2025.
If you suffered a loss on your The Cigna Group securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure





